Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone
about
Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesInhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in MiceVaccines: the Fourth CenturyExperimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesThe stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesProgress in the development of human parainfluenza virus vaccinesSevere acute respiratory syndrome coronavirus infection of golden Syrian hamsters.More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Nonsegmented negative-strand viruses as vaccine vectors.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsAttenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenContributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.Live-attenuated respiratory syncytial virus vaccines.Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.Respiratory syncytial virus infection: from biology to therapy: a perspective.Nipah virus: vaccination and passive protection studies in a hamster model.Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.Advances in vaccine technology and their impact on managed care.Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.Progress in respiratory virus vaccine development
P2860
Q26782411-DC342B35-AC94-493D-8B9D-927F57A9C9AEQ27490424-D2E583DA-3D67-4AF1-96D6-0D4F1B80A215Q27490454-10B16D50-A350-46F8-AD0C-91A2A77DB3B2Q30427591-088E97ED-8E55-4727-9153-6E1A79703788Q30440686-5F47A1DA-561A-4796-8E10-6DE22E4809B1Q34092801-3B7EC3B2-37BD-4DB9-8FB4-C3E9A10088D4Q34209872-F13EF2CD-7DD2-4A0A-9F10-9B0D0A4AB80EQ34376182-BF7EC601-6572-4868-83C8-52CD4918E67AQ34430473-B01A049B-7C13-4CF7-A7E6-0B57E6825693Q35139219-244EA513-6BF7-43D9-90E9-C85CB6AE246AQ35566601-561A23C2-ECBB-4979-8857-74417D5CAC79Q36086315-EA1118E0-BFBA-4855-8A82-630CF235A50BQ36099144-EC9520C2-8BCE-438D-883C-40D0C9189420Q36237057-F5794EBF-E493-4D18-8B55-EB28E634A8B2Q36433111-8467F8D7-0897-4812-B540-35CE0936976EQ36449078-190ADA6C-BE2A-4BB2-85EB-24E6F8787438Q36692801-687D2871-80A3-44E8-9607-E4737D057B57Q36827280-E13B3FD8-28BB-4B6E-8E75-4C8ABADA1FFAQ36834294-3414A868-A48D-4F3D-BE0F-C1D4DDD5E183Q36944615-458116F5-2018-4C69-9414-FB2821681B8BQ36961947-F97D061B-53E8-436D-8894-5647172A9328Q37313570-7EB1FF2F-BBF3-43D9-80BB-4CE0AC5A2D42Q37347267-3DF405F5-7352-482D-97A4-C5E19E6334CAQ37348134-D8011457-5F5A-4D08-A58B-159A265C1DE4Q37568127-F3BFFD00-B418-4064-A241-9DBFC74D2238Q37671603-C66210E9-8D17-4F0B-B52C-7476E16DE800Q37713895-016847B3-1980-42C9-9BE7-D801C62F9524Q39997643-200F4A37-1E3A-4260-BB87-A7C78E74DF80Q56894869-8EF5D58D-E12B-4F4F-9EC1-125D0B2021A8
P2860
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@ast
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@en
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@nl
type
label
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@ast
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@en
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@nl
prefLabel
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@ast
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@en
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@nl
P2093
P2860
P1433
P1476
Mucosal immunization of rhesus ...... a virus type 3 vector backbone
@en
P2093
Alexander C Schmidt
Brian R Murphy
Daniel R Wenzke
Josephine M McAuliffe
Marisa St Claire
Peter L Collins
William R Elkins
P2860
P304
P356
10.1128/JVI.76.23.12355-12359.2002
P407
P577
2002-02-01T00:00:00Z